DACOMITINIB ANHYDROUS
UNII 2XJX250C20

Substance Identification & Data

This profile provides standardized clinical and technical data for Dacomitinib Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2XJX250C20.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1110813-31-4 and the RxNorm Concept ID (RxCUI) 2058848. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2XJX250C20

CAS Registry Number

1110813-31-4

RxNorm Concept ID

2058848

Detailed Substance Profile

Preferred Name

DACOMITINIB ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

2XJX250C20

The specific atomic composition represented as a molecular structure string.

InChIKey

C24H25ClFN5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LVXJQMNHJWSHET-AATRIKPKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171723

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11511120

Unique identification number in the NCBI database of chemical substances.

INN ID

9314

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CCCN(C1)C\C=C\C(Nc2c(cc3c(c(Nc4ccc(c(c4)Cl)F)ncn3)c2)OC)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dacomitinib Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.